Edition:
United States

TRACON Pharmaceuticals Inc (TCON.OQ)

TCON.OQ on NASDAQ Stock Exchange Global Market

2.75USD
21 Jun 2018
Change (% chg)

$-0.15 (-5.17%)
Prev Close
$2.90
Open
$2.85
Day's High
$2.90
Day's Low
$2.75
Volume
40,806
Avg. Vol
24,646
52-wk High
$3.95
52-wk Low
$2.00

Chart for

About

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is... (more)

Overall

Beta: 2.11
Market Cap(Mil.): $89.19
Shares Outstanding(Mil.): 29.73
Dividend: --
Yield (%): --

Financials

  TCON.OQ Industry Sector
P/E (TTM): -- 244.89 34.04
EPS (TTM): -1.16 -- --
ROI: -51.53 -5.30 13.11
ROE: -62.07 -6.83 15.11

BRIEF-Tracon Pharmaceuticals Files For Offering Of Up To 27.4 Mln Shares Of Common Stock By The Selling Stockholders

* TRACON PHARMACEUTICALS INC FILES FOR OFFERING OF UP TO 27.4 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS Source text: [https://bit.ly/2KQef7f] Further company coverage:

May 10 2018

BRIEF-TRACON Pharmaceuticals Reports Qtrly Loss Per Share $0.46

* TRACON PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 09 2018

BRIEF-Tracon Pharmaceuticals Says Patricia Bitar Notified That Resigning As Co's CFO

* TRACON PHARMACEUTICALS INC - ON APRIL 30, PATRICIA L. BITAR NOTIFIED THAT RESIGNING AS CO'S CFO, EFFECTIVE JUNE 15, 2018- SEC FILING Source text for Eikon: (https://bit.ly/2w9w9yD) Further company coverage:

May 04 2018

BRIEF-Tracon Pharmaceuticals Says Regarding Election Of Ted Wang To Board, Board Approved Increase In Size From Six To Seven Members

* TRACON PHARMACEUTICALS SAYS REGARDING ELECTION OF TED WANG TO BOARD, BOARD APPROVED AN INCREASE IN SIZE FROM SIX TO SEVEN MEMBERS - SEC FILING Source text: (https://bit.ly/2JBtjFa) Further company coverage:

Apr 10 2018

BRIEF-Linden Capital Reports 9.9 Pct Passive Stake In Tracon Pharmaceuticals

* LINDEN CAPITAL L.P. REPORTS 9.9 PCT PASSIVE STAKE IN TRACON PHARMACEUTICALS INC AS OF MARCH 27, 2018 - SEC FILING Source text: [https://bit.ly/2pZqDIp] Further company coverage:

Apr 02 2018

BRIEF-TRACON Pharmaceuticals Announces $38.7 Million Private Placement

* TRACON PHARMACEUTICALS ANNOUNCES $38.7 MILLION PRIVATE PLACEMENT

Mar 23 2018

BRIEF-TRACON Pharma Qtrly Loss Per Share $0.37

* TRACON PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Feb 28 2018

Earnings vs. Estimates